• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

ADAM29促进胃癌细胞侵袭和生长的临床意义

Clinical significance of ADAM29 promoting the invasion and growth of gastric cancer cells .

作者信息

Chen Hongbing, Wang Siping

机构信息

Department of Gastrointenstinal Surgery, The Affiliated Yantai Yuhuangding Hospital of Qingdao University, Yantai, Shandong 264000, P.R. China.

Department of Emergency, Yantaishan Hospital, Yantai, Shandong 264001, P.R. China.

出版信息

Oncol Lett. 2018 Aug;16(2):1483-1490. doi: 10.3892/ol.2018.8838. Epub 2018 May 30.

DOI:10.3892/ol.2018.8838
PMID:30008827
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6036465/
Abstract

ADAM metallopeptidase domain 29 (ADAM29) belongs to the ADAM family, is a type I integral membrane protein and secrets a glycoprotein that mediates cell-cell and cell-matrix interaction. Aberrant expression of ADAM29 is involved in a number of physiological processes diversification. The purpose of the present study was to investigate the expression and biological effect of ADAM29 in human gastric cancer (GC) specimens and cell lines . The expression of ADAM29 was examined in 83 GC samples and 25 adjacent normal gastric tissues using quantitative reverse transcriptase-quantitative polymerase chain reaction and immunohistochemistry. The association between ADAM29 expression and cellular function of GC cells was assessed . The ADAM29 mRNA levels were significantly elevated in GC tissues compared with paracancerous tissues. Increased levels of ADAM29 were associated with high-grade staging and high Tumor-Node-Metastasis stages. Kaplan-Meier survival curves demonstrated that patients with GC and low ADAM29 transcript levels exhibited longer overall survival (OS) (P<0.01) and progression-free survival (PFS) time (P<0.01) compared with patients with high ADAM29 expression levels. ADAM29 significantly promoted the proliferation, migration and invasion of GC cells when overexpressed in MGC803 cells and knocked down in AGS cells. ADAM29 was increased in GC and the elevated expression of ADAM29 was associated with a poor survival rate of patients. ADAM29 may become a prognostic factor and therapeutic candidate for human GC.

摘要

ADAM金属蛋白酶结构域29(ADAM29)属于ADAM家族,是一种I型整合膜蛋白,可分泌介导细胞间和细胞与基质相互作用的糖蛋白。ADAM29的异常表达参与了许多生理过程的多样化。本研究的目的是探讨ADAM29在人胃癌(GC)标本和细胞系中的表达及生物学效应。采用定量逆转录-定量聚合酶链反应和免疫组织化学方法检测83例GC样本和25例癌旁正常胃组织中ADAM29的表达。评估ADAM29表达与GC细胞功能之间的关联。与癌旁组织相比,GC组织中ADAM29 mRNA水平显著升高。ADAM29水平升高与高分级分期和高肿瘤-淋巴结-转移分期相关。Kaplan-Meier生存曲线显示,与ADAM29高表达水平的患者相比,GC且ADAM29转录水平低的患者总生存期(OS)更长(P<0.01),无进展生存期(PFS)时间更长(P<0.01)。当在MGC803细胞中过表达并在AGS细胞中敲低时,ADAM29显著促进GC细胞的增殖、迁移和侵袭。GC中ADAM29升高,且ADAM29表达升高与患者生存率低相关。ADAM29可能成为人类GC的预后因素和治疗靶点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6cd2/6036465/58fe55c14dd8/ol-16-02-1483-g04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6cd2/6036465/886a123519ae/ol-16-02-1483-g00.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6cd2/6036465/abdd2b4d5bd0/ol-16-02-1483-g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6cd2/6036465/c4a56db9828e/ol-16-02-1483-g02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6cd2/6036465/a83daa063855/ol-16-02-1483-g03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6cd2/6036465/58fe55c14dd8/ol-16-02-1483-g04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6cd2/6036465/886a123519ae/ol-16-02-1483-g00.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6cd2/6036465/abdd2b4d5bd0/ol-16-02-1483-g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6cd2/6036465/c4a56db9828e/ol-16-02-1483-g02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6cd2/6036465/a83daa063855/ol-16-02-1483-g03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6cd2/6036465/58fe55c14dd8/ol-16-02-1483-g04.jpg

相似文献

1
Clinical significance of ADAM29 promoting the invasion and growth of gastric cancer cells .ADAM29促进胃癌细胞侵袭和生长的临床意义
Oncol Lett. 2018 Aug;16(2):1483-1490. doi: 10.3892/ol.2018.8838. Epub 2018 May 30.
2
ADAM29 Expression in Human Breast Cancer and its Effects on Breast Cancer Cells In Vitro.ADAM29在人乳腺癌中的表达及其对乳腺癌细胞的体外影响。
Anticancer Res. 2016 Mar;36(3):1251-8.
3
Expression of ADAM29 and FAM135B in the pathological evolution from normal esophageal epithelium to esophageal cancer: Their differences and clinical significance.ADAM29和FAM135B在食管正常上皮向食管癌病理演变过程中的表达:它们的差异及临床意义。
Oncol Lett. 2020 Mar;19(3):1727-1734. doi: 10.3892/ol.2020.11272. Epub 2020 Jan 9.
4
LAPTM4B-35, a cancer-related gene, is associated with poor prognosis in TNM stages I-III gastric cancer patients.LAPTM4B - 35是一种与癌症相关的基因,与TNM分期为I - III期的胃癌患者预后不良相关。
PLoS One. 2015 Apr 7;10(4):e0121559. doi: 10.1371/journal.pone.0121559. eCollection 2015.
5
HOXB13 expression and promoter methylation as a candidate biomarker in gastric cancer.HOXB13表达及启动子甲基化作为胃癌的候选生物标志物
Oncol Lett. 2018 Jun;15(6):8833-8840. doi: 10.3892/ol.2018.8371. Epub 2018 Mar 29.
6
Differential expression of CCN family members CYR611, CTGF and NOV in gastric cancer and their association with disease progression.CCN家族成员CYR611、CTGF和NOV在胃癌中的差异表达及其与疾病进展的关系。
Oncol Rep. 2016 Nov;36(5):2517-2525. doi: 10.3892/or.2016.5074. Epub 2016 Sep 8.
7
Upregulated expression of MNX1-AS1 long noncoding RNA predicts poor prognosis in gastric cancer.MNX1-AS1 长非编码 RNA 表达上调预示着胃癌预后不良。
Bosn J Basic Med Sci. 2019 May 20;19(2):164-171. doi: 10.17305/bjbms.2019.3713.
8
High expression of SMARCE1 predicts poor prognosis and promotes cell growth and metastasis in gastric cancer.SMARCE1的高表达预示着胃癌预后不良,并促进胃癌细胞的生长和转移。
Cancer Manag Res. 2019 Apr 23;11:3493-3509. doi: 10.2147/CMAR.S195137. eCollection 2019.
9
Activation of Transforming Growth Factor Beta 1 Signaling in Gastric Cancer-associated Fibroblasts Increases Their Motility, via Expression of Rhomboid 5 Homolog 2, and Ability to Induce Invasiveness of Gastric Cancer Cells.胃癌相关成纤维细胞中转化生长因子β 1 信号的激活通过表达菱形 5 同源物 2 增加其运动性,并增强诱导胃癌细胞侵袭的能力。
Gastroenterology. 2017 Jul;153(1):191-204.e16. doi: 10.1053/j.gastro.2017.03.046. Epub 2017 Apr 5.
10
Lipoprotein lipase expression is a novel prognostic factor in B-cell chronic lymphocytic leukemia.脂蛋白脂肪酶表达是B细胞慢性淋巴细胞白血病的一种新的预后因素。
Leuk Lymphoma. 2006 Jun;47(6):1053-61. doi: 10.1080/10428190500464161.

引用本文的文献

1
High Polygenic Risk Scores Positively Associated with Gastric Cancer Risk Interact with Coffee and Polyphenol Intake and Smoking Status in Korean Adults.高多基因风险评分与胃癌风险呈正相关,与韩国成年人的咖啡和多酚摄入量以及吸烟状况相互作用。
Nutrients. 2024 Sep 27;16(19):3263. doi: 10.3390/nu16193263.
2
Loss of ADAM29 does not affect viability and fertility in mice but improves wound healing.ADAM29缺失不影响小鼠的生存能力和生育能力,但可促进伤口愈合。
iScience. 2024 May 29;27(6):110135. doi: 10.1016/j.isci.2024.110135. eCollection 2024 Jun 21.
3
, , , , , and are highly expressed in colon cancer patients and are regulated by epigenetic alterations.

本文引用的文献

1
Molecular background of the regional lymph node metastasis of gastric cancer.胃癌区域淋巴结转移的分子背景
Oncol Lett. 2018 Mar;15(3):3409-3414. doi: 10.3892/ol.2018.7813. Epub 2018 Jan 16.
2
Effects of ADAM10 and ADAM17 Inhibitors on Natural Killer Cell Expansion and Antibody-dependent Cellular Cytotoxicity Against Breast Cancer Cells .ADAM10和ADAM17抑制剂对自然杀伤细胞扩增及对乳腺癌细胞的抗体依赖性细胞毒性的影响
Anticancer Res. 2017 Oct;37(10):5507-5513. doi: 10.21873/anticanres.11981.
3
Endoscopic gastroenterostomy: techniques and review.
在结肠癌患者中高度表达,并受表观遗传改变调控。 (注:原文中前面几个逗号处应是有具体基因等内容未给出完整,这里只能根据现有内容翻译)
Heliyon. 2023 Dec 14;10(1):e23689. doi: 10.1016/j.heliyon.2023.e23689. eCollection 2024 Jan 15.
4
Expression of in Gastric Cancer and its Relation to Tumor Cell Behavior and Prognosis.在胃癌中的表达及其与肿瘤细胞行为和预后的关系。
In Vivo. 2022 Sep-Oct;36(5):2194-2204. doi: 10.21873/invivo.12945.
内镜下胃肠造口术:技术与综述
Curr Opin Gastroenterol. 2017 Sep;33(5):320-329. doi: 10.1097/MOG.0000000000000389.
4
Upregulation of ADAM12 contributes to accelerated cell proliferation and cell adhesion-mediated drug resistance (CAM-DR) in Non-Hodgkin's Lymphoma.ADAM12的上调促成非霍奇金淋巴瘤中细胞增殖加速及细胞黏附介导的耐药性(CAM-DR)。
Hematology. 2017 Oct;22(9):527-535. doi: 10.1080/10245332.2017.1312205. Epub 2017 Apr 10.
5
ADAM17 promotes epithelial-mesenchymal transition via TGF-β/Smad pathway in gastric carcinoma cells.ADAM17通过TGF-β/Smad信号通路促进胃癌细胞的上皮-间质转化。
Int J Oncol. 2016 Dec;49(6):2520-2528. doi: 10.3892/ijo.2016.3744. Epub 2016 Oct 21.
6
ADAM9 silencing inhibits breast tumor cells transmigration through blood and lymphatic endothelial cells.ADAM9基因沉默可抑制乳腺肿瘤细胞通过血液和淋巴管内皮细胞的迁移。
Biochimie. 2016 Sep-Oct;128-129:174-82. doi: 10.1016/j.biochi.2016.08.006. Epub 2016 Aug 20.
7
The association between the duration of fluoropyrimidine-based adjuvant chemotherapy and survival in stage II or III gastric cancer.基于氟嘧啶的辅助化疗疗程与II期或III期胃癌患者生存率之间的关联。
World J Surg Oncol. 2016 Apr 2;14:102. doi: 10.1186/s12957-016-0845-1.
8
ADAM29 Expression in Human Breast Cancer and its Effects on Breast Cancer Cells In Vitro.ADAM29在人乳腺癌中的表达及其对乳腺癌细胞的体外影响。
Anticancer Res. 2016 Mar;36(3):1251-8.
9
Morbidity and Mortality of Laparoscopic Versus Open D2 Distal Gastrectomy for Advanced Gastric Cancer: A Randomized Controlled Trial.腹腔镜与开腹 D2 远端胃癌根治术治疗进展期胃癌的疗效比较:一项随机对照临床试验。
J Clin Oncol. 2016 Apr 20;34(12):1350-7. doi: 10.1200/JCO.2015.63.7215. Epub 2016 Feb 22.
10
[The importance of ADAM family proteins in malignant tumors].
Postepy Hig Med Dosw (Online). 2016 Feb 11;70:67-73. doi: 10.5604/17322693.1194615.